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The  Transient  Receptor  Potential  Canonical  5 (TRPC5)  protein  forms  calcium-permeable  cationic  chan-
nels  that  are  stimulated  by G protein-coupled  receptor  agonists.  The  signaling  pathways  of  such  agonist
effects  are  poorly  understood.  Here  we investigated  the  potential  for involvement  of  lysophosphatidyl-
choline  (LPC)  and arachidonic  acid generated  by group  6  (GVI)  phospholipase  A2 (PLA2)  enzymes,  focusing
on  stimulation  of TRPC5  by sphingosine-1-phosphate  (S1P)  which  acts  via  a  pertussis  toxin-sensitive
(Gi/o  protein)  pathway  without  Ca2+-release.  Experiments  were  on  HEK  293 cells  containing  conditional
expression  of  human  TRPC5.  Channel  activity  was  recorded  using  an  intracellular  calcium  indicator  or
whole-cell  patch-clamp  and  PLA2  activity  was  detected  using 3H-arachidonic  acid.  S1P stimulated  PLA2ransient receptor potential
hospholipase
phingosine-1-phosphate
ysophosphatidylcholine
and  TRPC5  activities.  Both  effects  were  suppressed  by  the  GVI  PLA2  inhibitor  bromoenol  lactone.  Knock-
down  of GVI  PLA2  by RNA interference  suppressed  channel  activity  evoked  by S1P  whereas  activity  evoked
by  the direct  channel  stimulator  LPC  was  unaffected.  Arachidonic  acid did  not  stimulate  the channels.
Prior  exposure  of channels  to  LPC  but  not  arachidonic  acid suppressed  channel  activity  evoked  by S1P
but  not  gadolinium,  a putative  direct  stimulator  of  the  channels.  The  data  suggest  roles  of LPC  and  GVI
PLA2  in  S1P-evoked  TRPC5  activity.. Introduction
Transient Receptor Potential Canonical 5 (TRPC5) is one of the
even mammalian TRPC proteins [1–4]. Like other TRPCs it is
hought to form non-selective, Ca2+-permeable, cationic channels
y organizing as a group of four proteins around a central ion pore
n the plasma membrane. In growth cones TRPC5 occurs as a homo-
er [5] but it also exist as heteromers with other widely expressed
RPC proteins, including TRPC1 and its most closely related and
unctionally similar protein, TRPC4 [1,2]. Messenger RNA encod-
ng TRPC5 has been most readily detected in the central nervous
ystem but wider expression occurs and is relevant to a variety of
rgans including brain, heart and vasculature [2,6–8].
From the earliest studies it was recognized that TRPC5 and other
RPC channels are stimulated by G protein-coupled receptor ago-
ists including ATP, acetylcholine, sphingosine-1-phosphate (S1P),
lutamate and cholecystokinin [7–12]. In some cases the recep-
or has needed to be over-expressed with TRPC5 but all available
ata support the principle that many agonists acting through G
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protein coupled receptors enhance TRPC5 function. The effects are
relevant to endogenous TRPC5-containing channels, for example
in S1P modulation of vascular smooth muscle cell migration [8]
and cholecystokinin modulation of fear responses in the amygdala
[7]. Despite knowledge of the existence and importance of receptor
stimulation of TRPC5, the signaling mechanisms mediating and reg-
ulating the process remain unclear. G protein activation is almost
certainly a key step after receptor-activation, as supported by the
observation that agonist effects are partially mimicked by intra-
cellular GTP--S (a stable analogue of guanosine triphosphate) and
inhibited by GDP--S (a stable analogue of guanosine diphosphate)
[8,10,13]. G proteins of the Gq/11 type have been implicated [13,14]
but the requirement is not absolute because activation by S1P or
oxidized phospholipids is blocked by pertussis toxin, which inhibits
Gi/o and not Gq/11 [8,15]. In HEK 293 cells, although acting via differ-
ent G proteins, endogenous muscarinic receptors and S1P receptors
couple apparently similarly to TRPC5 [8]. S1P is an example of an
agonist that activates TRPC5 and yet does not cause Ca2+-release
in HEK 293 cells [8]. Similarly, oxidized phospholipids stimulate
TRPC5 or TRPC1/5 channels without evoking Ca2+-release in HEK
293 cells or vascular smooth muscle cells [15].
Open access under CC BY license.It is also recognized that TRPC5 is a polymodal channel with a
multiplicity of stimulators including extracellular lanthanides (e.g.
gadolinium, Gd3+), extracellular or intracellular lysophosphatidyl-
choline (LPC), extracellular reduced thioredoxin and acidiﬁcation
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2,8,10,16–20].  Lanthanides appear to act directly via a glutamate
esidue near the ion pore, stabilizing the open state of the chan-
els [16]. Therefore, stimulation of TRPC5 by lanthanides in the
bsence of other exogenous stimulators [12] may  arise because
penings of constitutively active TRPC5 channels are prolonged.
PC also appears to act relatively directly because it is effective in
xcised membrane patches and when G proteins are blocked [17].
Here we investigated if Group 6 (GVI) phospholipase A2
nzymes are relevant to TRPC5 function. Group 6 was  selected
ecause it shows particular tendency to generate LPC (and related
ysophospholipids) and has been previously linked to agonist
ffects [21–25].  A commonly studied GVI PLA2 is GVIA (also called
PLA2) but we were led also to investigate an additional member,
VIB (also called iPLA2). The study focused particularly on stim-
lation of TRPC5 by the receptor agonist S1P. For comparison we
nvestigated effects of LPC and Gd3+.
. Methods
.1. Cell culture and TRPC expression
HEK-293 cells stably expressing tetracycline-regulated human
RPC5 have been described [12]. Cells were grown in DMEM-F12
edium containing 10% fetal calf serum, 100 U/ml penicillin and
00 g/ml streptomycin. Cells were maintained at 37 ◦C in 95%
ir/5% CO2 and selected with 250 g/ml zeocin and 10 g/ml blasti-
idin. TRPC expression was induced by 1 g/ml tetracycline (Tet+).
on-induced cells without addition of tetracycline were controls
Tet−). Cells were replated on poly-d-lysine-coated black 96-well
lates (Corning or BD Biosciences) or 13 mm  glass coverslips 24 h
rior to experiments.
.2. Ca2+ measurement
Induced (Tet+) and non-induced (Tet−) cells were plated at
bout 50% density in 96-well plates. Cells were incubated for
 h in 2 M ﬂuo-4 AM in standard bath solution (SBS) at 37 ◦C.
BS contained (mM):  130 NaCl, 5 KCl, 8 d-glucose, 10 HEPES,
.2 MgCl2 and 1.5 CaCl2; the pH was titrated to 7.4 with NaOH.
ells were washed three times with SBS at room temperature. The
lexStation II384 (Molecular Devices) was then used to measure
Ca2+]i and changes in response to substance addition. SBS was  the
ecording buffer and included a low concentration of gadolinium
Gd3+, 1 M)  to suppress background (non-TRPC5) channel activ-
ty. The FlexStation excited ﬂuo-4 at 485 nm and collected emission
t 525 nm.  Readings were made every 10 s. Pre-treatments with
 M lysophosphatidylcholine, 25 M bromoenol lactone or 10 M
rachidonic acid occurred for 30 min  at room temperature prior to
ecordings. Control cells were incubated in the solvent (vehicle)
nly.
.3. Whole cell voltage-clamp
Current recordings were made under voltage-clamp using the
hole-cell conﬁguration of the patch-clamp technique. Cells were
nvestigated on coverslips at 20–30% density. The bath solution was
BS. The patch pipette solution contained (mM):  135 CsCl, 2 MgCl2,
 EGTA, 10 HEPES, 5 Na2ATP and 0.1 Na2GTP; titrated to pH 7.2
ith NaOH and ﬁltered using a 0.2 m ﬁlter (Sartorius, UK). For LPC
xperiments, LPC was added to the pipette solution at 20 M or 0.1%
ethanol was the vehicle control; the two pipette solutions were
ompared alternately in paired experiments. The voltage paradigm
as a 200 ms  ramp protocol (−100 mV to +100 mV)  applied every
0 s from a holding potential of 0 mV.  Data were ﬁltered at 2 kHz
nd digitally sampled at 4 kHz.um 50 (2011) 343– 350
2.4. Short interfering (si) RNA
GVI PLA2 gene expression was  down-regulated using
a pre-designed siRNA sequence speciﬁc for GVIA PLA2
mRNA: 5′-GGAUCUCAUGCACAUCUCAtt-3′ (forward) and 5′-
UGAGAUGUGCAUGAGAUCCtg-3′ (reverse); and for GVIB PLA2
mRNA: 5′-CAUAGUAAAUAGAGGGAUAtt-3′ (forward) and 5′-
UAUCCCUCUAUUUACUAUGgt-3′ (reverse). HEK293-TRPC5 cells
were allowed to reach ∼60% density on a 100 mm petri dish and
then transfected with 1 M GVIA PLA2 siRNA (Ambion, siRNA ID#
139141), GVIB PLA2 siRNA (Ambion, siRNA ID# s27074) or mock
siRNA (Ambion, silencer® negative control #1 siRNA). In brief,
the transfection protocol was  as follows: Cells were washed with
10 ml phosphate-buffered saline (PBS), harvested using trypsin
and resuspended in DMEM-F12 medium. Cell suspension was
transferred to a 15 ml  tube and centrifuged at 200 × g for 10 min.
Supernatant was  decanted and the cell pellet resuspended in
0.2 ml  transfection reagent (Amaxa Cell Line Nucleofector Kit V).
To 0.1 ml,  100 M solution of the appropriate siRNA was added
(ﬁnal concentration, 1 M),  mixed and transferred to a cuvette of
a Nucleofector Kit V and submitted to nucleofection in an Amaxa
device. Cells were then transferred to 6-well plates and incubated
for 48 h. Cell selection antibiotics (blasticidin and zeocin) were
excluded from culture medium at this stage. Transfection efﬁciency
of 70–80% enabled functional assays using the FlexStation II384.
2.5. RT-PCR
Total RNA was isolated from HEK293-TRPC5 cells using
a standard TriReagent protocol and treated with DNAse
I (Ambion). 500 ng of this RNA was  used for cDNA syn-
thesis with oligo-dT primed AMV  reverse transcriptase
(+RT) and another aliquot was  processed while omitting
the reverse transcriptase (−RT). GVIA PLA2 PCR primer
sequences were: forward 5′-TGCCATGACCGAGATCC-3′
and reverse 5′-CTCGCGGTGCTCATAGA-3′. GVIB PLA2 PCR
primer sequences were: forward 5′-CGCAAGGGTGAGTATT-
3′ and reverse 5′-ATATGGCACCTGTGCTTA-3′. Cyclophilin
primers were: forward 5′-ACCCCACCGTGTTCTTCGAC-3′ and
reverse 5′-TGGACTTGCCACCAGTGCCA-3′. TRPC5 primers
were: forward 5′-GTCATCAAGCAAACGCT-3′ and reverse 5′-
AGGCTAGAGGGCATTC-3′. Real time PCR reactions were performed
with SYBR Green I on a LightCycler II (Roche, UK). Thermal cycling
started with a 10 min  hot start at 95 ◦C, then 40 cycles of: 95 ◦C
(10 s); 55 ◦C (6 s); and 72 ◦C (16 s). At the end of PCR cycling,
melting curve analysis was carried out by temperature ramping
from 65 to 95 ◦C with a transition heating rate of 0.1 ◦C/s.
2.6. PLA2 activity assay
PLA2 in HEK293-TRPC5 cells was assayed by quantiﬁcation of
3H-arachidonic acid released with or without stimulation [26,27].
Cells were seeded on poly-l-lysine coated 6-well plates and
induced with tetracycline. On the next day, 0.5 Ci 3H-arachidonic
acid (PerkinElmer) in 1 ml  culturing medium was added to each
well. After 24 h, cells were washed three times with PBS and kept for
30 min in the culture medium to recover. During this period, cells
were preincubated with 25 M BEL or the vehicle control (DMSO).
After three washes with PBS, cells were stimulated for 20 min  with
10 M S1P or vehicle in HEPES-Tyrode’s buffer (130 mM NaCl, 3 mM
KCl, 0.8 mM KH2PO4, 0.8 mM MgCl2, 10 mM HEPES, 5.5 mM glu-
cose, pH 7.4) containing 1.5 mM Ca2+. At the end of the incubation,
fatty acid-free BSA (Sigma) was  added to 0.3% ﬁnal concentration
to assist collection of released 3H-arachidonic acid. Liquid scini-
taillation counting was used to determine the amount of released
3H-arachidonic acid in cleared medium and the total radioactivity
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Fig. 1. Inhibition of S1P-evoked PLA2 activity and TRPC5 Ca2+ entry by bromoenol lactone (BEL). (a) The iPLA2 activity was monitored as 3H-arachidonic acid (3H-AA) release
in  TRPC5 expressing HEK 293 cells treated with vehicle, 10 M S1P or S1P after 25 M BEL preincubation (n/N = 6/18). S1P signiﬁcantly increased the AA release only in the
absence of BEL. (b–d) Fluo-4 Ca2+ measurements from HEK 293 cells induced (Tet+) or not induced (Tet−) to express TRPC5. (b) Example effect of 25 M BEL on the response
to  10 M S1P (N = 4). A small upward shift in the baseline is evident in the BEL group, which was statistically signiﬁcant (n/N = 4/16). (c) Example effect of 10 M (S)-BEL on
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RPC5  expression (n/N = 4/16). (S)-BEL did not cause a signiﬁcant shift in the baselin
rom cell monolayers solubilised in 0.1% Triton X-100. For each
ample the 3H-arachidonic acid release was quantiﬁed as the per-
entage of total radioactivity.
.7. Chemicals and reagents
Dimethylsulphoxide (DMSO) was the solvent for 50 mM bro-
oenol lactone (BEL) and 15 mM (S)-BEL and (R)-BEL stock
olutions. BEL compounds were from Cayman Chemical. Methanol
as the solvent for 50 mM lysophosphatidylcholine (LPC) stock
olution. Methanol was the solvent for 50 mM arachidonic acid
AA) and 10 mM sphingosine-1-phosphate (S1P) stock solutions.
ater was the solvent for 100 mM gadolinium (Gd3+) stock solu-
ions. Fluo-4 (2 M)  loading buffer included 8 M pluronic acid
Invitrogen) and freshly prepared 2 mM probenicid. Stock solutions
f 30% hydrogen peroxide (H2O2) and 200,000 U/ml catalase were
repared in SBS. For control experiments catalase was  denatured
y boiling it in solution for 10 min. Final concentrations of organic
olvents were ≤0.06%, v/v. Unless speciﬁed, chemicals were from
igma (UK)..8. Data analysis and presentation
Mean data are presented as mean ± standard error of the mean
SEM), where the n represents the number of independent experi-f S1P in Tet− cells (N = 4). (d) As for the example shown in (c) but the mean absolute
ithout (veh., vehicle) or with (S)-BEL treatment, and with or without induction of
+ signal (n/N = 4/16).
ments and the N represents the number of wells of a 96-well plate
used in a single experiment. For patch-clamp experiments, n was
the number of recordings from individual cells. ANOVA was used
for statistical comparison between the population means and the
unpaired Student t-test was used for comparisons between data
sets. P values < 0.05 were taken as indicating signiﬁcant difference.
Data were analyzed and presented using Origin software (Microcal
Inc., USA). Fluo-4 ﬂuorescence (F) values are indicated as F* where
* denotes that values were divided by 104.
3. Results
3.1. Stimulation of PLA2 activity by S1P
There was no prior information on whether S1P stimulated
PLA2 activity in HEK 293 cells and so the release of 3H-AA from
metabolically pre-labeled cells was measured as an indicator of
PLA2 activity. S1P caused a statistically signiﬁcant increase in 3H-
AA in HEK-TRPC5 cells, where as in the presence of the GVI PLA2
inhibitor BEL [28] there was no signiﬁcant increase caused by S1P
(Fig. 1a). The S1P data were further analyzed by normalizing the
3H-AA in the presence BEL to that in its absence (vehicle only);
these two S1P groups were signiﬁcantly different from each other
(P = 0.031), conﬁrming that BEL inhibited the S1P response. The data
suggest that S1P stimulated GVI PLA2 in HEK  293 cells.
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Fig. 2. (S)-BEL sensitivity of S1P responses in whole-cell voltage-clamp recordings. All recordings were for HEK 293 cells induced to express TRPC5 (Tet+ cells) except for a
subset  of labeled data in (d). (a) An example time-series plot for a response to 3 M S1P in the absence of (S)-BEL. Currents are shown for two points on the voltage ramp (−80
and  +80 mV)  and three time points are highlighted (i, ii, iii), which related to data in (b). 2-APB was applied at 75 M. (b and c) Example current–voltage (I–V) relationships
for  three time points (see a): (i) before application of S1P; (ii) at the maximum response to S1P; and (iii) after inhibition by 2-APB. (b) Control cell pre-incubated in DMSO
vehicle. (c) Test cell pre-incubated in 10 M (S)-BEL. (d) Mean data for currents induced by 3 M S1P at −80 or +80 mV in Tet+ (TRPC5) cells, recorded alternately after
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.2. Inhibition of S1P but not LPC responses by bromoenol lactone
BEL)
TRPC5 activity was measured using an intracellular Ca2+
ndicator (ﬂuo-4) to detect Ca2+-inﬂux in 96-well plate assays. Com-
arisons of different treatments were made within plates and, in
ach plate, cells induced (Tet+) and not induced (Tet−) to express
RPC5 were studied to determine the dependence on exogenous
RPC5 expression.
BEL in its racemic form inhibited TRPC5 activity that was stimu-
ated by S1P (Fig. 1b). Separate experiments were performed with
he (S) enantiomer of BEL which speciﬁcally inhibited the GVIA iso-
orm of PLA2 at low micromolar concentrations [28]. (S)-BEL had a
imilar effect to that of racemic BEL, partially inhibiting TRPC5 stim-
lation by S1P (Fig. 1c and d). The effect of (S)-BEL was  on the initial
esponse to S1P over 2–4 min, conferring on the overall response
 more sustained character (Supplementary Fig. I). There was  no
ffect of S1P or (S)-BEL on Ca2+ in the Tet− (control) cells (Fig. 1c
nd d). The lack of effect of S1P in Tet− cells is consistent with prior
ork showing that S1P did not evoke Ca2+-release from intracel-
ular stores in these cells [8]. LPC, a relatively direct stimulator of
RPC5 activity [17], evoked TRPC5-dependent Ca2+ entry that was
esistant to (S)-BEL (Fig. 1d).
The effect of (S)-BEL on S1P responses was also investi-
ated under voltage-clamp in whole-cell patch-clamp recordings
Fig. 2). In vehicle control cells, S1P evoked large ionic cur-
ents that were abolished by the non-speciﬁc TRPC5 inhibitor
-aminoethoxydiphenylborate (2-APB) (Fig. 2a) and showed the
ooked shape in the current–voltage relationship (I–V) with a
lateau between +5 and +25 mV,  which is a characteristic of TRPC5
Fig. 2b) [8,29].  The relatively linear I–V between −5 and −100 mV
ay  be a consequence of activity-dependent gating [30,31] and isr the lack of response to S1P in Tet− cells that were not induced to express TRPC5
characteristic of large TRPC5-mediated currents evoked by S1P [8].
In the presence of (S)-BEL, there was  basal TRPC5 activity but the
activity evoked by S1P was small (Fig. 2c). Only recordings in which
the characteristic TRPC5 I–V occurred were used for analysis. Non-
induced (Tet−) cells showed no current in response to S1P (Fig. 2d)
[8], conﬁrming that currents were mediated by TRPC5. The mean
data showed strong inhibition of S1P-evoked TRPC5-mediated cur-
rent by (S)-BEL (Fig. 2d).
3.3. Inhibition of S1P but not LPC responses by GVI PLA2
knock-down
To investigate the contribution of GVI PLA2 independently of
BEL we used RNA interference to knock-down the expression of GVI
PLA2 enzymes. Validation of the effectiveness and speciﬁcity of the
knock-down is shown in Supplementary Fig. II. There was a lower
density of cells after GVIA PLA2 knock-down (data not shown), con-
sistent with the role of GVIA PLA2 in S-phase progression [32]. In
an effort to compensate for this effect, cell number in test and con-
trol groups was  matched prior to Ca2+-measurements. Similar to
the effect of (S)-BEL, GVIA PLA2 siRNA partially inhibited TRPC5
activity evoked by S1P (Fig. 3a and c). In contrast, TRPC5 activity
evoked by LPC was  unaffected (Fig. 3b and c). There were no effects
in Tet− (control) cells (Fig. 3c). These data support the hypothesis
that GVIA PLA2 was involved in S1P-evoked TRPC5 activity.
As a further test of the speciﬁcity of (S)-BEL we investigated the
other enantiomer (R)-BEL, which was described to inhibit the GVIB
isoform but not GVIA PLA2 at low micromolar concentrations [28].
Perhaps surprisingly (R)-BEL inhibited S1P-evoked TRPC5 activity
(Fig. 3d), suggesting contribution also of GVIB PLA2. To further
investigate this suggestion we established speciﬁc knock-down
of GVIB PLA2 by siRNA (Supplementary Fig. II). GVIB PLA2 siRNA
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Fig. 3. Effects of GVIA and GVIB PLA2 knock-down. Data were obtained by Ca2+ measurement after transfection of cells with short interfering (si) RNA (a–d) or (R)-BEL (d). (a
and  b) Example effects of GVIA PLA2 siRNA (GVIA si) on responses to 10 M S1P (a) and 5 M LPC (b) in TRPC5-expressing cells (Tet+), except where data without expression
of  TRPC5 (Tet−) are shown for comparison. Each data set is from N = 4. (c) Mean data for experiments of the type shown in (a and b) (n/N = 4/24 each). (d) As for (c) but for
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easured 6 min  after application of LPC.
aused modest but signiﬁcant reduction in S1P-evoked TRPC5
ctivity without effect on stimulation by LPC (Fig. 3d). There were
o effects of (R)-BEL or GVIB PLA2 siRNA on Ca2+ in Tet− (con-
rol) cells (Fig. 3d). The data suggest that GVIB PLA2 made a small
ontribution to S1P-evoked TRPC5 activity.
.4. Inhibition of S1P but not Gd3+ responses by pretreatment
ith LPC
The initial products of GVI PLA2 are lysophospholipids and
rachidonic acid. Therefore, GVI PLA2 may  impact on TRPC5 by gen-
rating these lipid factors which then directly stimulate TRPC5. If
his was the case, application of exogenous lipid might mimic  and
cclude S1P-evoked TRPC5 activity.
LPC has non-speciﬁc detergent properties at high concentra-
ions, preventing use of a concentration that generated maximum
RPC5 activity. Cells were, therefore, incubated with a concentra-
ion of LPC that stimulated TRPC5 but did not evoke non-speciﬁc
ignals in control (Tet−) cells. In Tet+ cells, LPC stimulated a rise in
he intracellular Ca2+ concentration and suppressed the response
o S1P (Fig. 4a and c). In order to determine if the LPC-evoked Ca2+
ntry had simply saturated the Ca2+ indicator or maximized the
otal available TRPC5 activity we tested the effect of gadolinium
Gd3+), which is suggested to directly stimulate TRPC5 [16]. LPC
id not suppress the Gd3+ response but increased its rate of onset
Fig. 4b and c).
To further investigate the effect of LPC pretreatment we used
hole-cell patch-clamp recording, which enabled intracellular
elivery of LPC. Recording with LPC in the patch pipette tended
o yield spontaneous TRPC5 currents but the currents were not sta-
istically larger than those in the control group (Fig. 4d). Responses
o bath-applied S1P were, however, signiﬁcantly reduced in cells
ecorded with LPC in the patch pipette (Fig. 4d).ach) or GVIB PLA2 siRNA (GVIB si) (n/N = 5/15 each). (c and d) LPC responses were
It was previously reported that arachidonic acid had no effect
on TRPC5 [17]. However, we  re-investigated the effect of arachi-
donic acid in light of the new PLA2 data. Arachidonic acid failed to
stimulate TRPC5 and had no effect of S1P- or Gd3+-evoked activity
(Fig. 4e).
The data are consistent with lysophospholipids, exempliﬁed by
LPC, acting as second messengers coupling GVI PLA2 activity to
TRPC5.
3.5. Enhancement of Gd3+ responses by GVI PLA2 inhibition
In contrast to S1P- and LPC-evoked TRPC5 activities, Gd3+-
evoked TRPC5 activity was  enhanced by GVIA PLA2 siRNA, GVIB
PLA2 siRNA, BEL, (S)-BEL or (R)-BEL (Supplementary Fig. III), sug-
gesting a fundamentally different property of this mode of TRPC5.
We do not know the reason for the difference but we observed that
catalase prevented the effect (Supplementary Fig. III), suggesting
that endogenous H2O2 production was  involved [29].
4. Discussion
The data of this study suggest that GVI PLA2 and LPC are com-
ponents of a pathway that enables positive coupling between
activated S1P receptors and TRPC5 channels. Both chemical block-
ade and knock-down experiments supported this conclusion. LPC,
which was  previously shown to be a relatively direct stimulator
of the channels from the intracellular face of the membrane [17],
could occlude at least part of the S1P response and it appeared to act
downstream of GVI PLA2 because it stimulated the channels despite
the inhibition of GVI PLA2. The data add to prior publications
suggesting that Ca2+ channel regulation by PLA2s is important:
TRPM8 channel function was  linked to lysophospholipids and
GVIA PLA2 because application of intracellular or extracellular
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Fig. 4. Effects of lysophosphatidylcholine (LPC) and arachidonic acid (AA) on S1P and Gd3+ responses. The panels show Ca2+ measurement (a–c and e) and whole-cell patch-
clamp  (d) data from HEK 293 cells induced to express TRPC5 (Tet+). (a and b) Example comparisons of 10 M S1P (a) or 50 M Gd3+ (b) effects in the presence of 5 M LPC or
vehicle control (a, N = 8 each; b, N = 6 each). (c) Mean data for the types of experiment shown in (a and b) (n/N = 3/15 and n/N = 5/20 for S1P and Gd3+ respectively). (d) Mean
data  for basal whole-cell currents sampled 10 min  after break through to the whole cell (basal) and then evoked subsequently by 3 M S1P (S1P effect). Current amplitudes
w = 12) o
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ysophospholipid stimulated TRPM8 while stimulation of TRPM8 by
tore-depletion was suppressed by (S)-BEL [33,34];  and GVIA PLA2
as implicated in activation of endogenous non-selective cationic
hannels and voltage-gated Ca2+ channels [35,36].
There was quantitative discrepancy between the amplitude of
he GVI PLA2-dependent S1P response in Ca2+ measurement and
hole-cell patch-clamp experiments, with a stronger effect of PLA2
nhibition occurring in patch-clamp experiments (Fig. 2d cf. Fig. 1d).
atch-clamp is often considered to give a more direct measurement
f channel activity, without membrane potential changes, and with
ess modulation of the net signal by other mechanisms such as Ca2+
ptake and extrusion. If this view is accepted, our data suggest
hat GVI PLA2 had a major role in coupling S1P receptors to TRPC5
hannels. The Ca2+ measurement technique may  have conferred
mpliﬁcation of small, residual, TRPC5 signals as Ca2+ accumulated
n the cell and Ca2+ extrusion was attenuated as a consequence
f the reduced driving force on Na+–Ca2+ exchange resulting from
a+ inﬂux through the TRP channels [37]. Such effects may  be per-
inent to the observation that inhibition of GVI PLA2 changed the
haracter of the S1P response in Ca2+ measurement experiments,
iving the appearance of a reduced early but not late phase of the
esponse (Supplementary Fig. I); conceivably the S1P-evoked acti-
ation of TRPC5 was strongly suppressed but prolonged activation
f residual signal led to gradual accumulation of intracellular Ca2+.
Although our data support a role for GVI PLA2 and LPC in a path-
ay linking S1P receptors to TRPC5 channels it is premature to
xclude a cooperative or permissive role of this system with other
athways. Our data do not exclude such additional pathways in the
1P response or responses occurring via other receptors. Direct G
rotein effects on the channels, for example, are not excluded. Also,
n view of studies of other receptor-channel coupling mechanisms
nd widespread detection of channel sensitivity to PIP2 [38], a cou-
ling mechanism that deserves consideration is PIP2 depletion asr vehicle control (−LPC, n = 8) in the patch pipette solution. (e) Mean data as shown
a consequence of receptor-activation of phospholipase C (PLC). A
recent study identiﬁed SESTD1 protein as a partner of TRPC5 and
showed that it bound PIP2 [39]. Such a mechanism would operate
effectively for TRPC5 if: (i) the basal PIP2 concentration in unstim-
ulated cells inhibited TRPC5; (ii) agonist-evoked PIP2 depletion
was sufﬁcient to cause de-inhibition of TRPC5; and (iii) TRPC5 had
sufﬁcient constitutive activity or there was  concurrent presence
of a TRPC5 activator that enabled de-inhibition to release TRPC5
channel activity. Unfortunately, a PIP2-dependent mechanism sits
awkwardly with the available data which suggest that TRPC5 is
stimulated, inhibited or unaffected by PIP2 [40,41] and the ﬁnd-
ing that a related channel (TRPC4) is receptor-stimulated yet not
PIP2 sensitive [42]. Intriguingly, although S1P did not evoke Ca2+-
release, suggesting that it did not evoke inositol 1,4,5-triphosphate
(IP3) production or PLC activity, the PLC inhibitor U73122 inhib-
ited S1P-evoked TRPC5 activity [8].  The speciﬁcity of U73122 for
PLC is, however, not certain. Even if the effect of U73122 was due
to PLC inhibition, PLC may  be a co-factor for TRPC5 function or be
required for surface expression because we  have found that U73122
also inhibited Gd3+-evoked TRPC5 activity.
Other signals associated with PLC have been investigated as
potential intermediates in receptor-coupling to TRPC5 and these
may  be particularly relevant to receptor agonists that cause
Ca2+-release, such as acetylcholine and histamine. These other
PLC-related signals include increased concentrations of IP3, diacyl-
glycerol (DAG) and Ca2+ (resulting from IP3-induced Ca2+-release).
While one study suggested a role of IP3 in TRPC5 stimulation [13],
others found no effect of IP3 or IP3 receptor blockade [10,11,43,44].
There is agreement that DAG does not stimulate homomeric TRPC5
[10,13,20,45]. Neither S1P nor LPC evoked Ca2+-release or other
Ca2+ signals in HEK 293 cells in the absence of exogenous TRP
channel expression [8,17],  which not only suggested that PLC was
not activated but that elevated Ca2+ was  not the down-stream
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rior depletion of intracellular Ca2+ stores did not prevent S1P-
voked TRPC5 activity [8].  The data suggest that Ca2+-release is
ot critical in receptor-activation of TRPC5, but it could have
mportance, especially if the receptor agonist evokes Ca2+-release,
epetitive Ca2+ entry, or inhibition of Ca2+ extrusion. Ca2+ has
omplex effects on TRPC5. We  know it impacts on TRPC5 activity
ecause buffering of intracellular Ca2+ below the basal physiolog-
cal concentration depresses channel activity and elevated Ca2+
bove the basal concentration is a potentiating co-factor, most
otably with receptor agonists [46–48].  Therefore, intracellular
a2+ almost certainly has a positive modulator role in physiological
ffects on TRPC5. In summary, DAG is excluded as a stimulatory sig-
al coupling any receptor to TRPC5, and direct involvement of IP3
s unlikely. Roles of Ca2+ elevation and PIP2 depletion are likely in
ome contexts but neither seems to be a sufﬁcient or singular event
inking receptor to channel. There is no compelling evidence that
1P stimulates PLC in HEK 293 cells, despite it being a very effec-
ive stimulator of TRPC5. We  conclude that PLC activation, IP3 and
a2+-release are unlikely to be obligatory for receptor-activation of
RPC5.
Mechanistically it is unclear how catalase prevented the effect
f GVI PLA2 inhibition on Gd3+ responses. We  speculate that con-
titutive generation of H2O2 by mitochondria led to membrane
ipid peroxidation, priming TRPC5 channels for low-level activity.
asal activities of GVI PLA2s may  have then suppressed the process
y removing peroxidized phospholipids [25,49]. The effect of the
2O2 on TRPC5 would have become apparent in Gd3+ responses
ecause Gd3+ stabilized the open state of basally active channels.
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ot act by stabilizing the channel open state; that is, Gd3+ responses
ere proportional to constitutive (basal) activity of TRPC5, where
s other responses were not. Alternative hypotheses can be gener-
ted because there are complex house-keeping roles of GVI PLA2s
n maintaining membrane lipid integrity and TRPC5 is sensitive to
 range of different lipid factors [20,50,51].  All of these suggestions
re tentative and would required further investigation.
In summary, the study suggests that GVI PLA2 and LPC are
omponents in the coupling mechanism between S1P and TRPC5
hannels. Future studies will be required to determine the rel-
vance of these ﬁndings to endogenous TRPC5-containing and
elated channels of the cardiovascular and nervous systems
here lysophospholipids and PLA2 enzymes have important roles
52–56].
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